139 related articles for article (PubMed ID: 37266527)
1. Rifampicin Allergy Leading to Acute Renal Shutdown.
Jeyasekharan R; George N
Int J Appl Basic Med Res; 2023; 13(1):47-49. PubMed ID: 37266527
[TBL] [Abstract][Full Text] [Related]
2. Adverse effects of rifampin.
Grosset J; Leventis S
Rev Infect Dis; 1983; 5 Suppl 3():S440-50. PubMed ID: 6356277
[TBL] [Abstract][Full Text] [Related]
3. Acute rifampicin-associated interstitial tubulopathy in a patient with pulmonary tuberculosis: a case report.
Rosati S; Cherubini C; Iacomi F; Giannakakis K; Vincenzi L; Ippolito G; Palmieri F
J Med Case Rep; 2013 Apr; 7():106. PubMed ID: 23594801
[TBL] [Abstract][Full Text] [Related]
4. Reversible acute renal failure due to monthly administration of rifampicin in a leprosy patient.
Kar HK; Roy RG
Indian J Lepr; 1984; 56(4):835-9. PubMed ID: 6549453
[TBL] [Abstract][Full Text] [Related]
5. Acute renal failure complicating rifampicin therapy.
Prakash J; Kumar NS; Saxena RK; Verma U
J Assoc Physicians India; 2001 Sep; 49():877-80. PubMed ID: 11837753
[TBL] [Abstract][Full Text] [Related]
6. Rifampicin-induced disseminated intravascular coagulation in pulmonary tuberculosis treatment: A case report and literature review.
Chen G; He JQ
Medicine (Baltimore); 2017 Feb; 96(7):e6135. PubMed ID: 28207542
[TBL] [Abstract][Full Text] [Related]
7. API TB Consensus Guidelines 2006: Management of pulmonary tuberculosis, extra-pulmonary tuberculosis and tuberculosis in special situations.
API Consensus Expert Committee
J Assoc Physicians India; 2006 Mar; 54():219-34. PubMed ID: 16800350
[TBL] [Abstract][Full Text] [Related]
8. Acute renal failure caused by rifampicin re-exposure with 10-year of interval.
Tsai TL; Lee CH; Chuang FR; Hsu KT
Chang Gung Med J; 2001 Nov; 24(11):729-33. PubMed ID: 11820654
[TBL] [Abstract][Full Text] [Related]
9. Minimal change disease related to rifampicin presenting with acute renal failure during treatment for latent tuberculosis infection: A case report.
Kim JS; Kim KJ; Choi EY
Medicine (Baltimore); 2018 Jun; 97(22):e10556. PubMed ID: 29851774
[TBL] [Abstract][Full Text] [Related]
10. Acute tubulo-interstitial nephritis requiring dialysis associated with intermittent rifampicin use: case report.
Gallieni M; Braidotti P; Cozzolino M; Romagnoli S; Carpani P
Int J Artif Organs; 1999 Jul; 22(7):477-81. PubMed ID: 10493554
[TBL] [Abstract][Full Text] [Related]
11. Severe acute renal failure due to tubulointerstitial nephritis, pancreatitis, and hyperthyroidism in a patient during rifampicin therapy.
Paydas S; Balal M; Karayaylali I; Seyrek N
Adv Ther; 2005; 22(3):241-3. PubMed ID: 16236685
[TBL] [Abstract][Full Text] [Related]
12. Rifampicin-induced nephrotoxicity in a tuberculosis patient.
Beebe A; Seaworth B; Patil N
J Clin Tuberc Other Mycobact Dis; 2015 Nov; 1():13-15. PubMed ID: 31723676
[TBL] [Abstract][Full Text] [Related]
13. Adverse reactions to rifampicin.
Girling DJ; Hitze KL
Bull World Health Organ; 1979; 57(1):45-9. PubMed ID: 311712
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of anti-bacterial activity of Rifapentine, Clarithromycin, Minocycline, Moxifloxacin, Ofloxacin and their combinations in Murine Model of Rifampicin Resistant Leprosy.
Joseph P; Ponnaiya J; Das M; Chaitanya VS; Arumugam S; Ebenezer M
Indian J Lepr; 2016; 88(3):147-58. PubMed ID: 30207440
[TBL] [Abstract][Full Text] [Related]
15. Acute renal failure--a complication of new multidrug regimen for treatment of leprosy.
Dedhia NM; Almeida AF; Khanna UB; Mittal BV; Acharya VM
Int J Lepr Other Mycobact Dis; 1986 Sep; 54(3):380-2. PubMed ID: 3746041
[TBL] [Abstract][Full Text] [Related]
16. [Immunoallergic complication induced by rifampicin with disseminated intravascular coagulation].
Denis J; Robert A; Johanet C; Homberg JC; Opolon P; Levy VG
Presse Med; 1983 May; 12(23):1479-81. PubMed ID: 6222344
[TBL] [Abstract][Full Text] [Related]
17. Protocol, rationale and design of BE-PEOPLE (Bedaquiline enhanced exposure prophylaxis for LEprosy in the Comoros): a cluster randomized trial on effectiveness of rifampicin and bedaquiline as post-exposure prophylaxis of leprosy contacts.
Younoussa A; Samidine SN; Bergeman AT; Piubello A; Attoumani N; Grillone SH; Braet SM; Tsoumanis A; Baco A; Mzembaba A; Salim Z; Amidy M; Grillone S; Snijders R; Corstjens P; Ortuno-Gutierrez N; Hoof C; Geluk A; de Jong BC; Hasker E
BMC Infect Dis; 2023 May; 23(1):310. PubMed ID: 37161571
[TBL] [Abstract][Full Text] [Related]
18. Recurrent disseminated intravascular coagulation caused by intermittent dosing of rifampin.
Havey TC; Cserti-Gazdewich C; Sholzberg M; Keystone JS; Gold WL
Am J Trop Med Hyg; 2012 Feb; 86(2):264-7. PubMed ID: 22302861
[TBL] [Abstract][Full Text] [Related]
19. Case Report: Rifampicin-Induced Thrombocytopenia in a Patient with Borderline Lepromatous Leprosy.
Shui T; Shi C; Jing Z; Yang D; Zhu J
Am J Trop Med Hyg; 2020 Oct; 103(4):1441-1442. PubMed ID: 32748777
[TBL] [Abstract][Full Text] [Related]
20. Left thigh phlegmon caused by Nocardia farcinica identified by 16S rRNA sequencing in a patient with leprosy: a case report.
De Nardo P; Giancola ML; Noto S; Gentilotti E; Ghirga P; Tommasi C; Bellagamba R; Paglia MG; Nicastri E; Antinori A; Corpolongo A
BMC Infect Dis; 2013 Apr; 13():162. PubMed ID: 23556433
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
